by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
Palantir CEO Alex Karp stock sale: price impact and a day-trading playbook A new Palantir CEO, Alex Karp, stock sale disclosed via Form 4 shows 409,072 shares sold last week (automatic transactions tied to tax withholding on vested RSUs) at ~$142.46–$157.56. PLTR...
by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
NIO Stock Soars on ES8 Launch (Aug 2025) A cheaper ES8 with Battery‑as‑a‑Service, the new L90, and improving deliveries have investors re‑rating NIO. Here’s what changed—and how to trade it. What’s New · Why It Matters · Delivery Momentum · Rivals & Price War ·...
by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
US stablecoin rules deposit outflows — the fight over a “yield” loophole Bank trade groups want Congress to amend the new GENIUS Act because they say a loophole lets exchanges indirectly pay interest on third-party stablecoins. They argue that this could trigger US...
by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
xAI lawsuit against Apple and OpenAI over ChatGPT–iPhone integration Elon Musk’s xAI filed a federal antitrust complaint in Texas alleging that Apple’s integration of ChatGPT into iPhones and App Store promotion practices unfairly disadvantage rivals like Grok. Apple...
by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
Nvidia Jetson AGX Thor Robot Brain: A Fresh Catalyst for NVDA Nvidia’s new Nvidia Jetson AGX Thor robot brain platform—built on Blackwell—arrives with developer kits at $3,499 and production Jetson T5000 modules for scaled deployments. What launched—and why it matters...
by ADRIAN MANZ | Aug 25, 2025 | The Doctor's Dose
Tesla Stock Soars on Rate‑Cut Hopes (Aug 2025) Powell’s Jackson Hole remarks pushed rate‑cut odds higher and lifted risk assets—TSLA included. Meanwhile, Tesla’s new Cybertruck Luxe Package grabbed headlines but remains a sideshow to the rates story. Overview · Rates...
by ADRIAN MANZ | Aug 24, 2025 | The Doctor's Dose
Week Ahead: Nvidia earnings and PCE inflation gauge (Aug 25–29, 2025) In the wake of Fed Chair Jerome Powell’s Jackson Hole remarks, markets face a packed slate of economic data and high‑impact earnings—headlined by the Fed’s preferred inflation measure and Nvidia’s...
by ADRIAN MANZ | Aug 23, 2025 | The Doctor's Dose
Japanese Stocks Soar Despite Tariffs and Turmoil (Aug 2025) EWJ and key indices in Tokyo keep climbing even as the U.S. locks in 15% reciprocal tariffs and Japan’s ruling coalition loses its upper‑house majority. Here’s what’s driving the rally—and how to trade it....
by ADRIAN MANZ | Aug 20, 2025 | The Doctor's Dose
Estée Lauder Stock Plummets: Weak Guidance Spooks Investors Estée Lauder stock (EL) plummets after the cosmetics giant reported in-line earnings but issued soft guidance for the fiscal year ahead. Despite adjusted EPS of $0.09 on revenue of $3.41B—both in line with...
